Skip to main content

Virtual Collaborative Care: Moving From Recognition to Implementation of Mental Health Integration in Community Oncology

Mental Health
July 2026, Vol 16, No 4

Introduction

Depression and anxiety affect up to 40% of patients with cancer and are consistently associated with lower quality of life, reduced treatment adherence, increased healthcare utilization, and poorer clinical outcomes.1,2 Despite this well-established burden, routine treatment of mental health conditions remains inconsistently integrated into oncology practice—including in community settings, where access to behavioral health specialists is often limited.

Validated screening tools such as the PHQ-9 and GAD-7 are widely available, endorsed by professional societies, and increasingly embedded in electronic health records.3 However, screening alone has not translated into sustained increases in engagement with mental health support for cancer patients. In many practices, a positive screen triggers an external referral, leaving patients to navigate a separate system at a time when they are already coping with the physical and emotional demands of cancer. Not surprisingly, a substantial proportion of patients never connect with care, and distress remains untreated despite being identified.4

Recent commentaries have clearly outlined the scope and urgency of unmet mental health needs in community oncology.5 What remains less well described is how evidence-based behavioral health integration can be operationalized within routine oncology workflows and whether such models deliver measurable benefit in real-world practice.5,6

Oncologists do not need convincing that mental health matters. We see it daily—patients who miss visits because of overwhelming anxiety, struggle with adherence during depression, or quietly disengage from care while appearing clinically stable. The challenge in community oncology has never been awareness. It has been execution.

The problem is not a lack of evidence or reimbursement pathways, but the absence of scalable infrastructure that aligns behavioral healthcare with oncology workflows. Virtual collaborative care offers a pragmatic alternative. By embedding psychiatric expertise and structured, measurement-based symptom monitoring directly into oncology care—without requiring in-person visits—this model moves mental health from recognition to implementation, leveraging telemedicine to overcome geographic barriers and optimize specialist time, thus creating truly scalable infrastructure. Furthermore, it improves the patient experience by meeting them where they are and markedly improves access to these much-needed services.

Real-World Evidence From a Virtual Collaborative Care Model

Our recent retrospective analysis evaluated 207 patients with breast cancer enrolled in a virtual collaborative care program delivered through Cerula Care. Participants were predominantly female (mean age, 56 years) and racially diverse (58% White, 32% Black/African American), reflecting the population commonly treated in community oncology practices. These findings were presented as a poster at the San Antonio Breast Cancer Symposium on December 12, 2025.

Patients received coordinated behavioral health support from a virtual multidisciplinary team that included:

  • A consulting psychiatrist with expertise in psycho-oncology
  • A behavioral healthcare manager
  • A behavioral health coach

Care followed a measurement-based, treatment-to-target approach, a core principle of effective collaborative care.7,8 Monthly assessments were conducted using validated instruments:

  • PHQ-9 for depression
  • GAD-7 for anxiety
  • FACT-G7 for cancer-specific quality of life

Weekly interdisciplinary case reviews allowed the team to adjust care plans and escalate treatment for patients who were not improving—without adding visit volume, or documentation burden for oncology clinicians.

The results were clinically meaningful. By month 5 of participation:

  • PHQ-9 scores decreased by approximately 6.6 points, shifting many patients from moderate to mild depression and helping many others achieve sustained remission
  • GAD-7 scores decreased by approximately 4.8 points, reflecting meaningful reductions in anxiety

These changes are consistent with outcomes observed in prior collaborative care trials in oncology and other chronic disease populations.7,8

Quality of life, as measured by FACT-G7, improved over time. Notably, Black patients experienced greater gains in quality-of-life scores compared with White patients. While exploratory, this finding suggests that reducing access barriers through virtual, integrated behavioral healthcare may help address persistent inequities in supportive oncology services.9

Mental health improvements also translated into outcomes that matter directly to cancer care delivery. Among surveyed participants:

  • 70% reported improved ability to keep oncology appointments
  • 65% reported better adherence to nonchemotherapy medications

In oncology, engagement, adherence, and follow-up are not secondary outcomes—they are foundational to treatment success.10,11

Why Traditional Approaches Fall Short

Despite widespread distress screening, many oncology practices rely on passive, referral-based models that place the burden of coordination on patients already stretched thin by cancer treatment. One-time screening without longitudinal follow-up, long wait times for behavioral health appointments, and limited psycho-oncology expertise contribute to high rates of untreated depression and anxiety.

Distress screening should occur at defined clinical moments—diagnosis, treatment transitions, disease progression—and be paired with clear pathways for follow-up. Screening without response is not care.

This gap reflects a systems failure rather than a clinical one. Oncologists recognize the problem but often lack the infrastructure to manage mental health conditions longitudinally within existing workflows.

Virtual collaborative care addresses this gap by shifting responsibility from individual clinicians and patients to structured, team-based systems of care.

Practical Guidance: How to Integrate Mental Health Into Daily Oncology Practice

Effective mental health integration does not require oncologists to become psychiatrists. It requires systems.

1. Normalize and Act on Screening

Distress screening should occur at defined clinical moments—diagnosis, treatment transitions, disease progression—and be paired with clear pathways for follow-up. Screening without response is not care.3 Patients frequently underreport mental health symptoms to their oncologists.12 Even if they do not screen positive on evaluation, all patients with a new cancer diagnosis should be educated about how to access mental health resources.13

2. Close the Loop on Referrals and Communication

Avoid “hand-off” referrals that rely on patients to navigate external systems. Integrated or virtual programs that proactively contact patients and report back to oncology teams achieve far higher engagement.6,8

3. Use Measurement-Based Care

Track symptoms longitudinally using validated tools. Let data—not intuition alone—guide escalation or adjustment of care. Measurement-based care is a defining feature of effective collaborative care models.7,8

4. Preserve Oncology Bandwidth

Successful models deliver behavioral health expertise without increasing visit volume, inbox burden, or documentation demands—an essential requirement for sustainability in community practice.

5. Design for Equity

When access barriers are removed, outcomes improve—particularly for historically underserved patients. Equity must be built into care models, not addressed retrospectively.9

Conclusion

Mental health integration in oncology has been recognized as important, yet implementation has lagged behind evidence. Experience with virtual collaborative care suggests that this gap reflects the limitations of traditional delivery models rather than lack of clinical awareness or motivation.

Real-world data demonstrate that embedding measurement-based behavioral healthcare into oncology workflows is feasible in community practice and associated with meaningful improvements in depression, anxiety, quality of life, and patient engagement. Importantly, this efficient model—requiring minimal new infrastructure and reducing operational burden—also aligns with existing reimbursement pathways for collaborative care. This creates a sustainable financial foundation, making integrated mental health support not only clinically beneficial but also a viable, long-term service offering for community oncology practices. Early equity signals further highlight the importance of addressing access barriers through thoughtful system design.

For oncology practices, the implications are practical. Behavioral healthcare does not need to compete with cancer-directed treatment or add to clinician burden when supported by appropriate infrastructure—it can actually improve quality of work for oncologists. Models that align with existing workflows and optimize resource utilization for financial sustainability offer a realistic path toward more comprehensive, patient-centered cancer care. Integrating virtual collaborative care into community oncology practices represents a practical population health solution that benefits all stakeholders in cancer care. By thoughtfully implementing this model, we have an opportunity to change the way patients living with cancer access mental health services, and we encourage oncology practices to proactively investigate and pilot these evidence-based models to ensure truly comprehensive patient support.

References

  1. Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of interview-based studies. Lancet Oncol. 2011;12:160-174.
  2. Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415.
  3. Andersen BL, DeRubeis RJ, Berman BS, et al. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: ASCO guideline adaptation. J Clin Oncol. 2014;32:1605-1619.
  4. Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer. Lancet Psychiatry. 2014;1:343-350.
  5. Jones TG, Cleary E, Sedhom R, McAneny BL. Integrating mental health into cancer care: a community oncology imperative. ASCO Post. December 10, 2025.
  6. Fann JR, Ell K, Sharpe M. Integrating psychosocial care into cancer services. J Clin Oncol. 2012;30:1178-1186.
  7. Sharpe M, Walker J, Hansen CH, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2). Lancet. 2014;384:1099-1108.
  8. Katon WJ, Lin EHB, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363:2611-2620.
  9. Cook BL, Trinh N-H, Li Z, et al. Trends in racial-ethnic disparities in access to mental health care, 2004–2012. Psychiatr Serv. 2017;68:9-16.
  10. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment. Arch Intern Med. 2000;160:2101-2107.
  11. Mausbach BT, Schwab RB, Irwin SA. Depression as a predictor of adherence to adjuvant endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2015;152:239-246.
  12. Miller MF, Olson JS, Fortune EE. Attitudinal and accessibility barriers predict unmet mental health care needs in distressed cancer patients and survivors. Psychooncology. 2025;34:e70333.
  13. Andersen BL, Lacchetti C, Ashing K, et al. Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update. J Clin Oncol. 2023;41:3426-3453.